These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9685372)
21. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins. Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927 [TBL] [Abstract][Full Text] [Related]
23. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase. Grucza RA; Bradshaw JM; Mitaxov V; Waksman G Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995 [TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of small chemical inhibitors containing different scaffolds for lck SH2 domain. Park SH; Kang SH; Lim SH; Oh HS; Lee KH Bioorg Med Chem Lett; 2003 Oct; 13(20):3455-9. PubMed ID: 14505648 [TBL] [Abstract][Full Text] [Related]
25. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src. Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171 [TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity. Jin LL; Wybenga-Groot LE; Tong J; Taylor P; Minden MD; Trudel S; McGlade CJ; Moran MF Mol Cell Proteomics; 2015 Mar; 14(3):695-706. PubMed ID: 25587033 [TBL] [Abstract][Full Text] [Related]
27. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia. Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059 [TBL] [Abstract][Full Text] [Related]
28. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study. Bradshaw JM; Grucza RA; Ladbury JE; Waksman G Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054 [TBL] [Abstract][Full Text] [Related]
29. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes. Kristensen SM; Siegal G; Sankar A; Driscoll PC J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283 [TBL] [Abstract][Full Text] [Related]
30. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305 [TBL] [Abstract][Full Text] [Related]
32. High-resolution structural analysis shows how different crystallographic environments can induce alternative modes of binding of a phosphotyrosine peptide to the SH2 domain of Fer tyrosine kinase. Matsuura Y Protein Sci; 2019 Nov; 28(11):2011-2019. PubMed ID: 31441171 [TBL] [Abstract][Full Text] [Related]
33. The Src homology-2 domains (SH2 domains) of the protein tyrosine kinase p56lck: structure, mechanism and drug design. Broadbridge RJ; Sharma RP Curr Drug Targets; 2000 Dec; 1(4):365-86. PubMed ID: 11467076 [TBL] [Abstract][Full Text] [Related]
34. A quantum mechanical study on phosphotyrosyl peptide binding to the SH2 domain of p56lck tyrosine kinase with insights into the biochemistry of intracellular signal transduction events. Pichierri F Biophys Chem; 2004 May; 109(2):295-304. PubMed ID: 15110947 [TBL] [Abstract][Full Text] [Related]
35. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases. Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072 [TBL] [Abstract][Full Text] [Related]
36. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides. Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554 [TBL] [Abstract][Full Text] [Related]
37. Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Eck MJ; Atwell SK; Shoelson SE; Harrison SC Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222 [TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics. Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160 [TBL] [Abstract][Full Text] [Related]
39. Role of solution conformation and flexibility of short peptide ligands that bind to the p56(lck) SH2 domain. Dekker FJ; de Mol NJ; Bultinck P; Kemmink J; Hilbers HW; Liskamp RM Bioorg Med Chem; 2003 Mar; 11(6):941-9. PubMed ID: 12614879 [TBL] [Abstract][Full Text] [Related]
40. SH2-directed ligands of the Lck tyrosine kinase. Lee TR; Lawrence DS J Med Chem; 2000 Mar; 43(6):1173-9. PubMed ID: 10737750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]